Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0000950170-24-009406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-31 | 2024-01-29 | DYN | Brumm Joshua T | CEO, Pres, Dir | G - Gift | $0.00 | -21.5K | 563.5K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | G | D | 20,000 | $0.00 | 564,971 | D | — | — | (F2) Includes 552,729 unvested RSUs. |
| 2 | Common | Common Stock | 2024-01-29 | G | D | 1,500 | $0.00 | 563,471 | D | — | — | (F2) Includes 552,729 unvested RSUs. |